ITFISA
TXG icon

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s 10x Genomics TXG Stock Holding History

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,400
Closed -$66.1K – 192
2024
Q2 		$66.1K Hold
3,400
– – 0.03% 136
2024
Q1 		$122K Buy
+3,400
New +$149K 0.05% 128

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's TXG Position: Q3 2024 in Review

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold out of 10x Genomics (TXG) in Q3 2024, closing a stake of 3,400 shares — an estimated $66.1K sold.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in TXG in Q1 2024 and held it in 2 quarters. The position peaked at $122K in Q1 2024. 266 funds tracked by Wall St. Rank hold TXG as of Q3 2024.

  • Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna reported no remaining 10x Genomics position as of Q3 2024 after selling out during the quarter.
  • Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold 3,400 10x Genomics shares in Q3 2024, an estimated $66.1K.
  • Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in 10x Genomics in Q1 2024 and held it in 2 quarters.
  • Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's 10x Genomics position peaked at $122K in Q1 2024.
  • 266 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2024.

Based on Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's 13F filing for Q3 2024, filed 29 Aug 2025.